Around the world, almost 10 million people are infected with the disease – mostly in Central and South America and parts of the USA. Tourism and immigration, however, are also bringing the disease to Europe.
Microfluidic cartridge with integrated reagents and pumps, developed as part of the Fraunhofer ivD platform
Photo: Fraunhofer ENAS / Andreas Morschhauser
One bite can have fatal consequences
The disease is passed on by blood-sucking bugs of the Reduviidae family, whose bite contaminates the wound and ultimately transmits the infection. The acute phase of the illness starts after four weeks and can last up to another four weeks. 30 – 40% of infected people have symptoms such as local redness, swelling around the wound, fever, and nausea. Treatment is only effective if started in this phase of the illness.
After a symptomless stage, which can last for years, the chronic, acute and frequently fatal phase of the illness begins. In 20% of cases, the heart and alimentary organs expand until they fail.
Scientists are concerned because there is still no inoculation. Current methods of treatment not only have serious side effects, they are also unaffordable for many patients.
Effective test offers a chance for a treatment
Under the direction of Fraunhofer ENAS, a European-Brazilian consortium is developing an on-site test, similar to a laboratory analysis, that can detect the infection quickly and reliably.
Scientists from eight European and five Brazilian research institutions and companies are developing a compact, low-cost detection system that can find the pathogen at any location. Three partners of the Heterogeneous Technology Alliance HTA are among them: CEA Leti from France, the Fraunhofer Institute for Electronic Nanosystems ENAS from Germany, and Teknologian tutkimuskeskus VTT from Finland.
The pathogen is detected in, say, a blood sample by searching for both its own DNA and the immune response from the patient’s body. The test allows highly specific diagnosis in all stages of the infection. Including sample pretreatment, the entire test system is the size of a cellular phone.
The researchers are receiving funding from the European Union and the National Council for Scientific and Technological Development in Brazil. The project “PodiTrodi – Technology platform for Point-of-care diagnostics for tropical diseases“ (EU-FP7-287770) started in September 2011 and was planned to run for two and a half years. The system will later be used as a technology platform for other tropical diseases.
Further information is available at http://www.poditrodi.org.European consortium:
• Universidade Federal do Paraná
CRISPR meets single-cell sequencing in new screening method
19.01.2017 | CeMM Forschungszentrum für Molekulare Medizin der Österreichischen Akademie der Wissenschaften
Toward a 'smart' patch that automatically delivers insulin when needed
18.01.2017 | American Chemical Society
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
19.01.2017 | Ecology, The Environment and Conservation
19.01.2017 | Awards Funding
19.01.2017 | Studies and Analyses